Moderna’s groundbreaking coronavirus vaccine was designed in just 2 days

Business Insider Australia | Nov 26, 2020 at 5:16 PM
  • Moderna’s coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials, the company announced last week.
  • So Moderna’s coronavirus vaccine candidate works by injecting a small piece of mRNA from the coronavirus that codes for the virus’ spike protein.
  • Two days later, Moderna’s team and NIH scientists had finalised the targeted genetic sequence it would use in its vaccine.